2010 -

1. (2010/10/04)
4
202

10 10

(4105) 90 155
(1701)(1716)(3176)4
8500 ECFA

20 20 50

2011
5
25
2010 Q4
2 AmtelMosoprid
6000 3 2011 4

4 (FDA)

9 29 60 (4142) H1N1
8 H5N1

(/ )

2010 -

100 10
4 4 3 2
20 1 68.25 7080
AIDS

20 800

B C AIDS
H1N1H5N1
FDA
PI-88

FDA (SPA) 2014

3 80
4 30 50
2010 H1 600 600
9403 H1 6000
FDA 2012

(/ )

2010 -
2. (2010/10/04)

11

25
57

ODM 11 200

3. (2010/10/04)

10 5 7

MMF DCS
Abbott
Mylan Depakote ER 2009 4 2010

Abbott

2009

(/ )

2010 -
2008
2010 9
900-1,000 8-12 5600
2009 19 120
5 2008

FDA File

2006
130 2007 150 2008 180 2009 210
2015 280

4. 600

(2010/10/05)
600 6

40%
600 50

5. (2010/10/05)
(/ )

2010 -
4 NDM-1 NDM-1

TVBS

NDM-1
NDM-1

6. (2010/10/05)

10

9
10 5 7

7. 15%GDP(2010/10/05)

(/ )

2010 -

GDP 1% 15%
10

8. (2010/10/06)
BTC5

BTC 15

BTC
BTC

9. (2010/10/06)
171617315
(/ )

2010 -

30
5

50
25 40
10% 9 2.7 7.29% 8 3.1
30

10. TDR(2010/10/07)
17166

TDR
13 1.2

11. 9 (2010/10/07)
9 15654126
(4102) (1733)
4128

200 138
297 250

12. (2010/10/08)
41287

20
3.66 250.61% 54.5 0.7
8

1
(/ )

2010 -
13. 9 (2010/10/08)
4120 9
2 3 8 14.4 24.36
4.94 9 40.79

NOV

14. (2010/10/11)

14 CRO

BTC

15. (2010/10/11)

10

30

16. (2010/10/13)
910312 600
1.85

13
(/ )

2010 -

TDR 47%
2 6.9 1,916 0.05

17. (2010/10/14)
15 17
13

190419051907
9

18. (2010/10/14)
172013

13 0.2%
2.42% 2.48% 35.25

1.09
12 30

200

55 765
11

19. (2010/10/14)
1701
29
(/ )

2010 -
30

200
25

20. (2010/10/15)
410514
6

GemmisR
Gemzar

21. (2010/10/15)

95%

7 9
14

22. UCB(2010/10/15)
412014 UCB UCB

60.8 0.8 679

UCB

UCB

23. ECFA (2010/10/15)

ECFA
(/ ) 10

2010 -
ECFA

10 13 ECFA

ECFA

24. (2010/10/15 )

95

25. (2010/10/15 )
FDA 13 Fosamax
Boniva
1% FDA
5 FDA
15 FDA

FDA
Bisphosphonates
Actone Atelvia
Reclast FDA 500 FDA

26. (2010/10/15 )
(/ ) 11

2010 -
10

WC P&G
10

10 1

Warner Chilcott

MPM Capital

27. (2010/1015 )
4120
UCB
UCB

Cimzia (certolizumab pegol)

Vimpatlacosamide Neuprorotigotine

UCB
Vimpat Neupro

UCB

UCB

40 9,000 2009 31
UCB

1.41 7.16

1.74

28. 10 (2010/10/15 )
Warner
ChilcottWC 10 Warner Chilcott

MRSA
(/ ) 12

2010 -
MRSA
MRSA

2004 12 PG
FDA Warner Chilcott 3

Warner Chilcott Warner

Chilcott (upfront fee)

(milestones) (royalty)
sales threadhold

IMS 12
Warner Chilcott 2009 10 31
WC2010 15.77

29. (2010/10/18)

200 80

41048
11
17161734
11

17314128
30

(/ ) 13

2010 -

30. (2010/10/18)

ECFA
ECFA

31. (2010/10/18)

24

(/ ) 14

2010 -
1 1 2

DNA
Gamma

4,600 260 1.35

15 5 93 330

24

32. (2010/10/18)

(/ ) 15

2010 -

Warner ChilcottWC

P&G
cmc FDA

SCB01 FDA FDA

9 SCB01 bench bed

FDA
(/ ) 16

2010 -
FDA

FDA

FDA

33. (2010/10/18 )
3000 2020

16

+
(/ ) 17

2010 -

34. (2010/10/18 )

(/ ) 18

2010 -

9.6

700
9 6578
2 2012 518

700

35.

(2010/10/19)

414218
(/ ) 19

2010 -
1 Crucell
7 23
9 74 9 4,718
22 1 9 7.76 507 10 6
10 9 1.3 7
FDA
9,000

36. (2010/10/19)
1716 2019
52 286

6
BEBioequivalence
4 20 5
3 20-30

37. (2010/10/20)

6
FDA

SFDA
FDA SFDA
FDA SDFA

38. (2010/10/20)
12 FDA
(/ ) 20

2010 -
FDA

FDA()
SFDA()
SFDA FDA SDFA

FDA

FDA
FDA

10 2223 11 1

39. (2010/10/20)
Pharma3.0

Carolyn
Buck Luce 1.0
2.0 3.0

3.0
(/ ) 21

2010 -

1.0
2.0 Pharma
3.0

40. (2010/10/21)
20 1.3
7,750
1.3

41. (2010/10/21)
1707 3
2.56 3

3.7-3.8
1.72 29.31% 1.32

240 50
60
4.8 3.65 3
2 9 3

42. (2010/10/22)
1711
7.22 411% 1.85 20%

(/ ) 22

2010 -
46.83 28.7% 5.22
488% 7.22 411% 1.85

6.3
6.5
2013

43. EPS 5 (2010/10/22)

4126 3 2.7
5.4 5 4 EPS
7
9 3,213 3,042 3.26
1-9 2 5,955 2.75 2.7 EPS 5
40.5 38.28
130
140
9
41.9 3 40.85
40

44. (2010/10/22, )
(22)(
)

FDA()

(/ ) 23

2010 -
45. Amgen (2010/10/25)
1970~1980
1980 10
Amgen
EpogenEPO Amgen 1980 4 8
AMgenApplied Molecular Genetics1983
Amgen
Amgen Thousand Oaks

Amgen Epogen
GenentechBiogen Idec 1980
Amgen Genentech
Biogen Idec Biogen Idec
Bill BowesFrank JohnsonSam Wohlsteader MIT
Raymond Baddour 4 3
CEO George Rathmann

George Rathmann
UCLA
UCLA 1,890

EPO Erythropoietin
red blood cellsRBC

EPO EPO

EPO 2003
EPO EPO
EPO

1984 EPO
3 1 1989 6 5
(/ ) 24

2010 -
1990 FDA 2 1991
70 8
2 2006~2007 150
2 550

46. (2010/10/25, )
6

911 1300 4

FDA
FDA

SFDA
FDA SFDA

FDA

FDA
FDA
20 3
FDA 7 11 2

47. (2010/10/25)
(/ ) 25

2010 -

2 1 肽
肽

肽

(/ ) 26

2010 -

11 18

48. 10 (2010/10/25)

10

25
50

49. (2010/10/27)
X

IEK 4

30 40 50

(26)

(/ ) 27

2010 -
50. (2010/10/28)

5%

51. EPS 13.15 (2010/10/29)

1565 13.15
6.63

52. (2010/10/29)
ITC4103
93.09%28 400
62.5 1.3

(/ ) 28